Development of a unified list of drugs associated with drug-induced cognitive impairment

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1103860

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This research will develop a comprehensive list of drugs probably impairing cognition. These drugs will be identified from a large spontaneous reporting system in combination with those from published literature. The association of identified drugs and cognitive impairment will be tested using prescription sequence symmetry analyses in Pharmaceutical Benefits Scheme claims database and validated through formal epidemiological studies in Australian ongoing longitudinal population-based cohorts.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2019

Funding Scheme: Targeted Calls

Funding Amount: $443,573.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmacology and Pharmaceutical Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adverse drug reactions | cognitive decline | data mining | meta-analysis | pharmacoepidemiology

Related Links